Interaction of ivermectin with multidrug resistance proteins (MRP1, 2 and 3)

Chemico-Biological Interactions

Volumn 159, Issue 3, 2006, Pages 169-179

  Lespine, Anne ^a   Dupuy, Jacques ^a   Orlowski, Stéphane ^b   Nagy, Tünde ^c   Glavinas, Hristos ^c   Krajcsi, Peter ^c,d   Alvinerie, Michel ^a  

^a CEMAGREF   (France)

^b CEA SACLAY   (France)

^c SOLVO BIOTECHNOLOGY   (Hungary)

^d SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Antiparasitic therapy; Drug transport; Ivermectin; Macrocyclic lactones; Multidrug protein (MRP); Multidrug resistance; Multidrug resistance reversion; P glycoprotein (Pgp)

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CALCEIN; IVERMECTIN; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; DRUG TRANSPORT; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN EXPRESSION;

ADENOSINE TRIPHOSPHATASES; ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE; CELL MEMBRANE; GENE EXPRESSION REGULATION; HUMANS; IVERMECTIN; MOLECULAR STRUCTURE; P-GLYCOPROTEINS; SPODOPTERA; SUBSTRATE SPECIFICITY; SWINE;

ANIMALIA;

EID: 30944466044     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2005.11.002     Document Type: Article

References (43)

1. D.H. Molyneux, M. Bradley, A. Hoerauf, D. Kyelem, and M.J. Taylor Mass drug treatment for lymphatic filariasis and onchocerciasis Trends Parasitol. 19 2003 516 522
2. Q.A. McKellar, and H.A. Benchaoui Avermectins and milbemycins J. Vet. Pharmacol. Ther. 19 1996 331 351
3. M.M. Gottesman, and I. Pastan Biochemistry of multidrug resistance mediated by the multidrug transporter Annu. Rev. Biochem. 62 1993 385 427
4. G.Y. Kwei, R.F. Alvaro, Q. Chen, H.J. Jenkins, C.E. Hop, C.A. Keohane, V.T. Ly, J.R. Strauss, R.W. Wang, Z. Wang, T.R. Pippert, and D.R. Umbenhauer Disposition of ivermectin and cyclosporin A in CF-1 mice deficient in mdr1a P-glycoprotein Drug Metab. Dispos. 27 1999 581 587
5. A. Roulet, O. Puel, S. Gesta, J.F. Lepage, M. Drag, M. Soll, M. Alvinerie, and T. Pineau MDR1-deficient genotype in Collie dogs hypersensitive to the P-glycoprotein substrate ivermectin Eur. J. Pharmacol. 460 2003 85 91
6. A.H. Schinkel, J.J. Smit, O. van Tellingen, J.H. Beijnen, E. Wagenaar, L. van Deemter, C.A. Mol, M.A. van der Valk, E.C. Robanus-Maandag, and H.P. te Riele Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs Cell 77 1994 491 502
7. C.M. Laffont, P.L. Toutain, M. Alvinerie, and A. Bousquet-Melou Intestinal secretion is a major route for parent ivermectin elimination in the rat Drug Metab. Dispos. 30 2002 626 630
8. D.R. Hennessy, S.W. Page, and D. Gottschall The behaviour of doramectin in the gastrointestinal tract, its secretion in bile and pharmacokinetic disposition in the peripheral circulation after oral and intravenous administration to sheep J. Vet. Pharmacol. Ther. 23 2000 203 213
9. M. Alvinerie, J. Dupuy, C. Eeckhoutte, and J.F. Sutra Enhanced absorption of pour-on ivermectin formulation in rats by co-administration of the multidrug-resistant-reversing agent verapamil Parasitol. Res. 85 1999 920 922
10. J. Dupuy, G. Larrieu, J.F. Sutra, C. Eeckhoutte, and M. Alvinerie Influence of verapamil on the efflux and metabolism of 14C moxidectin in cultured rat hepatocytes J. Vet. Pharmacol. Ther. 24 2001 171 177
11. J. Dupuy, G. Larrieu, J.F. Sutra, A. Lespine, and M. Alvinerie Enhancement of moxidectin bioavailability in lamb by a natural flavonoid: quercetin Vet. Parasitol. 112 2003 337 347
12. M. Xu, M. Molento, W. Blackhall, P. Ribeiro, R. Beech, and R. Prichard Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog Mol. Biochem. Parasitol. 91 1998 327 335
13. N.C. Sangster, S.C. Bannan, A.S. Weiss, S.C. Nulf, R.D. Klein, and T.G. Geary Haemonchus contortus: sequence heterogeneity of internucleotide binding domains from P-glycoproteins Exp. Parasitol. 91 1999 250 257
14. Y.N. Korystov, N.V. Ermakova, L.N. Kublik, M. Levitman, V.V. Shaposhnikova, V.A. Mosin, V.A. Drinyaev, E.B. Kruglyak, T.S. Novik, and T.S. Sterlina Avermectins inhibit multidrug resistance of tumor cells Eur. J. Pharmacol. 493 2004 57 64
15. D. Lautier, Y. Canitrot, R.G. Deeley, and S.P. Cole Multidrug resistance mediated by the multidrug resistance protein (MRP) gene Biochem. Pharmacol. 52 1996 967 977
16. P. Borst, R. Evers, M. Kool, and J. Wijnholds The multidrug resistance protein family Biochim. Biophys. Acta 1461 1999 347 357
17. T.H. Chang, K. Hakamada, Y. Toyoki, S. Tsuchida, and M. Sasaki Expression of MRP2 and MRP3 during liver regeneration after 90% partial hepatectomy in rats Transplantation 77 2004 22 27
18. M. Buchler, J. Konig, M. Brom, J. Kartenbeck, H. Spring, T. Horie, and D. Keppler cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats J. Biol. Chem. 271 1996 15091 15098
19. J.F. Pouliot, F. L'Heureux, Z. Liu, R.K. Prichard, and E. Georges Reversal of P-glycoprotein-associated multidrug resistance by ivermectin Biochem. Pharmacol. 53 1997 17 25
20. C.J. Bachmeier, W.J. Trickler, and D.W. Miller Drug efflux transport properties of 2′,7′-bis(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester (BCECF-AM) and its fluorescent free acid, BCECF J. Pharm. Sci. 93 2004 932 942
21. Z. Hollo, L. Homolya, C.W. Davis, and B. Sarkadi Calcein accumulation as a fluorometric functional assay of the multidrug transporter Biochim. Biophys. Acta 1191 1994 384 388
22. A. Bodo, E. Bakos, F. Szeri, A. Varadi, and B. Sarkadi The role of multidrug transporters in drug availability, metabolism and toxicity Toxicol. Lett. 140-141 2003 133 143
23. B. Sarkadi, E.M. Price, R.C. Boucher, U.A. Germann, and G.A. Scarborough Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase J. Biol. Chem. 267 1992 4854 4858
24. I. Leier, G. Jedlitschky, U. Buchholz, M. Center, S.P. Cole, R.G. Deeley, and D. Keppler ATP-dependent glutathione disulphide transport mediated by the MRP gene-encoded conjugate export pump Biochem. J. 314 Pt 2 1996 433 437
25. M. Garrigos, L.M. Mir, and S. Orlowski Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase - further experimental evidence for a multisite model Eur. J. Biochem. 244 1997 664 673
26. E. Bakos, R. Evers, E. Sinko, A. Varadi, P. Borst, and B. Sarkadi Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions Mol. Pharmacol. 57 2000 760 768
27. L.B. Goh, K.J. Spears, D. Yao, A. Ayrton, P. Morgan, C. Roland Wolf, and T. Friedberg Endogenous drug transporters in in vitro and in vivo models for the prediction of drug disposition in man Biochem. Pharmacol. 64 2002 1569 1578
28. A.H. Schinkel, E. Wagenaar, L. van Deemter, C.A. Mol, and P. Borst Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A J. Clin. Invest. 96 1995 1698 1705
29. I.C. van der Sandt, M.C. Blom-Roosemalen, A.G. de Boer, and D.D. Breimer Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines Eur. J. Pharm. Sci. 11 2000 207 214
30. O. Legrand, J.Y. Perrot, R. Tang, G. Simonin, S. Gurbuxani, R. Zittoun, and J.P. Marie Expression of the multidrug resistance-associated protein (MRP) mRNA and protein in normal peripheral blood and bone marrow haemopoietic cells Br. J. Haematol. 94 1996 23 33
31. T. Lehmann, C. Kohler, E. Weidauer, C. Taege, and H. Foth Expression of MRP1 and related transporters in human lung cells in culture Toxicology 167 2001 59 72
32. N. Feller, H.J. Broxterman, D.C. Wahrer, and H.M. Pinedo ATP-dependent efflux of calcein by the multidrug resistance protein (MRP): no inhibition by intracellular glutathione depletion FEBS Lett. 368 1995 385 388
33. A.L. Dogan, O. Legrand, A.M. Faussat, J.Y. Perrot, and J.P. Marie Evaluation and comparison of MRP1 activity with three fluorescent dyes and three modulators in leukemic cell lines Leuk. Res. 28 2004 619 622
34. D. Schwab, H. Fischer, A. Tabatabaei, S. Poli, and J. Huwyler Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery J. Med. Chem. 46 2003 1716 1725
35. J. Taipalensuu, H. Tornblom, G. Lindberg, C. Einarsson, F. Sjoqvist, H. Melhus, P. Garberg, B. Sjostrom, B. Lundgren, and P. Artursson Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers J. Pharmacol. Exp. Ther. 299 2001 164 170
36. T.P. Schaub, J. Kartenbeck, J. Konig, O. Vogel, R. Witzgall, W. Kriz, and D. Keppler Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules J. Am. Soc. Nephrol. 8 1997 1213 1221
37. R. Evers, M. Kool, L. van Deemter, H. Janssen, J. Calafat, L.C. Oomen, C.C. Paulusma, R.P. Oude Elferink, F. Baas, A.H. Schinkel, and P. Borst Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA J. Clin. Invest. 101 1998 1310 1319
38. H. Potschka, M. Fedrowitz, and W. Loscher Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity J. Pharmacol. Exp. Ther. 306 2003 124 131
39. A.T. Nies, G. Jedlitschky, J. Konig, C. Herold-Mende, H.H. Steiner, H.P. Schmitt, and D. Keppler Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain Neuroscience 129 2004 349 360
40. H. Sun, H. Dai, N. Shaik, and W.F. Elmquist Drug efflux transporters in the CNS Adv. Drug Deliv. Rev. 55 2003 83 105
41. J. Wijnholds, E.C. deLange, G.L. Scheffer, D.J. van den Berg, C.A. Mol, M. van der Valk, A.H. Schinkel, R.J. Scheper, D.D. Breimer, and P. Borst Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier J. Clin. Invest. 105 2000 279 285
42. S. Cisternino, C. Mercier, F. Bourasset, F. Roux, and J.M. Scherrmann Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier Cancer Res. 64 2004 3296 3301
43. A.D. Didier, and F. Loor Decreased biotolerability for ivermectin and cyclosporin A in mice exposed to potent P-glycoprotein inhibitors Int. J. Cancer 63 1995 263 267